DKSH, a leading provider of Market Expansion Services, has announced a strategic partnership with Bayer to enhance the distribution and promotion of Bayer Pharmaceuticals’ products in Singapore, Malaysia, Thailand, and the Philippines.
This collaboration aims to improve patient access to Bayer’s cardiovascular products and women’s health retail portfolio in the region.
The partnership leverages DKSH’s extensive expertise in healthcare solutions, including its robust distribution infrastructure and integrated commercial and medical affairs capabilities. Ashraf Al-Ouf, Head of Commercial Operations at Bayer Pharmaceuticals APAC, expressed enthusiasm about the collaboration, stating, “DKSH’s extensive healthcare expertise and robust commercial capabilities in Southeast Asia position them as an ideal partner for us.”
Bijay Singh, Global Head of DKSH Business Unit Healthcare, highlighted the significance of the partnership, noting that each market has unique healthcare system nuances. “We are thrilled to embark on this partnership with Bayer,” he said. “We are confident we can help increase patient access whilst ensuring compliance and quality.”
This alliance marks a significant step in continuing patient care and accessibility in Southeast Asia, as both companies aim to navigate the evolving market landscape and drive sustainable growth. By combining their resources and expertise, DKSH and Bayer are committed to uplifting the healthcare ecosystem in the region, ultimately delivering better healthcare outcomes for patients.
“`
